Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

After 14 years of follow-up, data from the Göteborg trial in Sweden show that PSA-based screening is associated with a halving of deaths due to prostate cancer. The Göteborg study, which ...

The article by Thompson et al. has caused significant uproar with regard to the utility of PSA for detecting prostate cancer. A few comments and cautions are warranted. We have long suspected that ...

Such studies using PSA velocity to trigger biopsy would help to better characterize its role in prostate cancer screening, and to elucidate the specific patient subgroups for whom it has ...

In summary, it seems that obese men with a low risk of developing prostate cancer have lower serum PSA levels than their non-obese counterparts; the presence of prostate cancer might attenuate ...